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Radial Neuropathy Exacerbated by Ligamentous
Laxity in Pregnancy and by Chemotherapy: A
Case ReportJoel Castellanos, MD (University of Michigan, Ypsilanti, Michigan,
United States), Sean R. Smith, MD
Disclosures: Joel Castellanos: I Have No Relevant Financial Relation-
ships To Disclose
Case/Program Description: A 32-year-old right-handed woman with
metastatic malignant mixed Mullerian tumor (MMMT) presented with
left upper extremity numbness, tingling, and pain along her posterior
forearm, thumb, and second digit. She developed mild symptoms
during pregnancy 7 months prior, and severe symptoms three months
before presentation after receiving carboplatin and paclitaxel
chemotherapy for MMMT. Four years earlier, she also experienced a
milder form of these symptoms; electromyography (EMG) found no
abnormalities and the symptoms resolved spontaneously. Of note, her
history is significant for numerous left shoulder subluxations requiring
reduction.
Setting: Outpatient cancer rehabilitation clinic.
Results: Physical examination revealed decreased strength in left
elbow extension (4-/5) and wrist extension (4/5), absent left triceps
reflex, and diminished pinprick sensation over the posterior forearm
with increased sensitivity to light touch over the distal radial nerve
distribution. Computerized tomography of her neck and chest did not
reveal neural foraminal narrowing or metastatic disease to explain
her symptoms. On EMG testing, radial sensory nerve conduction
studies (NCS) were not recordable, and radial motor studies at the
forearm showed decreased amplitude compared to the right side
(1.7mV vs 3.7mV) with comparable distal latencies. Median and ulnar
motor and sensory NCS were normal. Needle electromyography
revealed positive waves, fibrillations, and chronic changes in the
extensor carpi radialis brevis, brachioradialis, and extensor indicis,
but not the triceps, suggesting an incomplete chronic axonal neu-
ropathy proximal to the brachioradialis. Deltoid, biceps brachii,
pronator teres, and first dorsal interosseus (hand) had no abnormal
EMG findings.
Discussion: Repetitive shoulder subluxation likely created tension on
the radial nerve at the spiral groove of the humerus, causing a stretch
injury. Ligamentous laxity in pregnancy caused symptoms to recur, and
chemotherapy worsened the injury to the point of axonotmesis.
Conclusions: Pregnancy may exacerbate neuropathies associated
with ligamentous laxity, and chemotherapy can worsen pre-existing
neuropathies.
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ALS Masked by Breast Cancer History and Low Back
Pain: A Case ReportPatrick Dolan, MD (SUNY Downstate Medical Center, Brooklyn, NY,
United States), Bhavi Patel, DO, Marcel G. Bayol, MD
Disclosures: Patrick Dolan: I Have No Relevant Financial Relationships
To Disclose
Case/Program Description: A 56-year-old African American woman
with a past medical history of hypertension and ductal carcinoma in
situ of the breast (treated by resection and radiation) was evaluated
for worsening leg and arm weakness. She had leg weakness requiring
the use of a cane. She later developed arm weakness resulting in
decreased grip with her cane and almost daily falls. She also noted
low back pain and occasional urinary incontinence. There was
concern for metastases or a paraneoplastic syndrome from her breast
cancer history but CT and MRI of the head revealed no new changes.
CT of the spine revealed L3-S1 disk herniations (L3/4, L4/5, L5/S1) so
she was given two epidural steroid injections for possible lumbar
radiculopathy. Her symptoms continued to worsen with new vocalhoarseness accompanied by shortness of breath. On initial exam, she
was found to have 4/5 muscle strength with 3+ hyperreflexia
throughout, upgoing plantar reflex bilaterally and a positive jaw jerk
reflex. She was able to transfer independently and exhibited a very
slow and narrow, unsteady gait. Otherwise, the rest of her exami-
nation was within normal limits. Workup including antibodies, in-
flammatory markers, and infectious etiologies were all negative
except for a CK of 777. MRI of spine corroborated previous CT find-
ings. After no imaging or laboratory abnormalities pointed to any
diagnosis, EMG was performed leading to Amyotrophic Lateral Scle-
rosis (ALS) diagnosis. Patient was subsequently transferred to acute
inpatient rehab then referred to outpatient movement disorder
specialist for further care.
Setting: Inpatient Acute Rehabilitation Facility.
Results: EMG demonstrated reduced amplitude, prolonged latencies,
or decreased conduction velocity in right median and ulnar motor
nerves, right medial sensory nerve, right peroneal motor and sensory
nerves, and right sural sensory nerve.
Discussion: This case demonstrates the importance of physical exam
and significance of inpatient electrodiagnostic studies in helping to
establish or confirm a diagnosis.
Conclusions: Based on our physical examination revealing UMN/LMN
signs with LMN findings corroborated by EMG and absence of other
more likely diagnoses this patient demonstrates ALS.
Level of Evidence: Level VPoster 281
The Adult Spasticity International Registry (ASPIRE
Study): Baseline Demographics and Clinical
Characteristics of Patients Treated for SpasticityGerard E. Francisco, MD (University of Texas and TIRR Memorial,
Houston, TX, United States), Daniel Bandari, Ganesh Bavikatte,
Wolfgang H. Jost, MD, PhD, Aubrey Manack Adams, PhD, Joan Largent,
Alberto Esquenazi, MD
Disclosures: Gerard Francisco: Research Grants - Allergan, Research
Grants - Merz, Research Grants - Mallinckrodt, Research Grants - Ipsen,
Research Grants - Nexstim, Research Grants - Micro transponder
Objective: To describe baseline demographics and clinical charac-
teristics in patients treated with onabotulinumtoxinA for spasticity.
Design: Multicenter, prospective, observational registry study
(NCT01930786).
Setting: Select clinical sites in North America, Europe, and Asia.
Participants: Patients with spasticity of multiple etiologies, including
those naı¨ve to and previously treated with onabotulinumtoxinA.
Interventions: OnabotulinumtoxinA treatments administered per
routine care.
Main Outcome Measures: Primary objectives were to assess onabo-
tulinumtoxinA treatment utilization, patient/physician treatment
satisfaction, and botulinum toxin treatment incidence for other in-
dications among adult spasticity patients treated with onabotuli-
numtoxinA. Baseline demographics and clinical characteristics as of
September 10, 2015 are summarized (enrollment completed
September 11, 2015).
Results: A total of 727 patients were enrolled in ASPIRE and treated
by 63 healthcare providers (69.4% PM&R’s) across France, Germany,
Italy, Spain, Taiwan, UK, and USA (n¼54 sites). More patients (n¼602/
715, 84.2%) had lower limb spasticity (most common: equinovarus foot
[35.2%] and extended knee [16.1%]), than upper limb spasticity
(n¼513/716, 71.2%; most common: flexed elbow [22.4%] and clenched
fist [21.5%]). At baseline, 36.8% (n¼268) of patients were botulinum
toxin naı¨ve for spasticity treatment. Patients with spasticity due to
stroke (58.1%), multiple sclerosis (15.7%), other etiologies (10.1%),
cerebral palsy (9.8%), traumatic brain injury (5.9%), and spinal cord
injury (5.4%), were on average 53.7 years old, majority were Caucasian
(77.4%), and gender was nearly evenly distributed (52.1% female).
Patients were mainly on disability (44.2%) and had a caregiver (57.9%;
